Harvard Bioscience
(HBIO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,307 | -2,987 | -1,349 | -636 | -19,039 |
| Depreciation Amortization | 4,365 | 3,357 | 2,241 | 1,096 | 4,659 |
| Income taxes - deferred | -279 | 455 | 4 | 4 | 15,116 |
| Accounts receivable | 566 | 2,145 | 959 | -463 | -1,340 |
| Accounts payable and accrued liabilities | -2,413 | -2,785 | -2,459 | -2,679 | 2,577 |
| Other Working Capital | -41 | -473 | -2,377 | -1,981 | -2,719 |
| Other Operating Activity | 7,492 | 3,944 | 3,197 | 3,933 | 1,451 |
| Operating Cash Flow | $5,383 | $3,656 | $216 | $-726 | $705 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,445 | -920 | -402 | -201 | -2,954 |
| Net Acquisitions | 1,417 | N/A | N/A | N/A | -4,545 |
| Other Investing Activity | -34 | -34 | -10 | -4 | -18 |
| Investing Cash Flow | $-62 | $-954 | $-412 | $-205 | $-7,517 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,000 | 3,000 | 2,000 | 1,000 | 5,800 |
| Debt Repayment | -9,050 | -6,738 | -4,625 | -2,613 | -8,350 |
| Common Stock Issued | 182 | 80 | -9 | -113 | 2,042 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -32 |
| Financing Cash Flow | $-4,868 | $-3,658 | $-2,634 | $-1,726 | $-540 |
| Exchange Rate Effect | -1,601 | -443 | -283 | 88 | -38 |
| Beginning Cash Position | 6,744 | 6,744 | 6,744 | 6,744 | 14,134 |
| End Cash Position | 5,596 | 5,345 | 3,631 | 4,175 | 6,744 |
| Net Cash Flow | $-1,148 | $-1,399 | $-3,113 | $-2,569 | $-7,390 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,383 | 3,656 | 216 | -726 | 705 |
| Capital Expenditure | -1,445 | -920 | -402 | -201 | -2,960 |
| Free Cash Flow | 3,938 | 2,736 | -186 | -927 | -2,255 |